Quinoline derivatives as phosphodiesterase inhibitors
US7572915B2 · kind B2 · utility
7Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2006 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Jul 19, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
There are provided according to the invention novel compounds of formula (I)or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.